In addition, FTO polymorphisms in intron 1 have been linked to a range of human cancers, yet a recent meta-analysis study suggested that except for pancreatic cancer the increased cancer risk is rather associated to obesity than the FTO polymorphism itself [65]. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.